Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02821793Completed

Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer

Role: collaborator

NCT03529383Not ApplicableCompleted

Efficacy of Exercise Using Connected Activity Trackers and Therapeutic Education in Localized Breast Cancer

Role: collaborator

NCT03429296Not ApplicableCompleted

Autohypnosis and Cancerology

Role: collaborator

NCT04117048Not ApplicableCompleted

INR at Home Measurement by the LabPad® Point-of-care in Patients on Vitamin K Antagonist Drugs (VKA)

Role: collaborator

NCT02486887Not ApplicableUnknown

Home Electronic Monitoring of Chronic Heart Failure

Role: collaborator

All 5 trials loaded